Unknown

Dataset Information

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer.


ABSTRACT:

Objective

Although the utility of immunohistochemistry (IHC) for assessing mismatch repair (MMR) protein expression has been demonstrated in solid tumors including primary prostate cancer (PCa), its utility has not been assessed in castration-resistant PCa (CRPC).

Methods

Tissue microarrays were constructed from 127 radical prostatectomies and 155 CRPC metastases from 50 patients. MMR (MLH1, MSH2, MSH6, and PMS2) expression was assessed by IHC and gene expression arrays. Associations between MMR protein expression in PCa and CRPC and biochemical recurrence (BCR) or time from diagnosis to death respectively were determined.

Results

There was no correlation between levels of MMR protein and BCR. Absence of MSH2 and MSH6 was the most pronounced at 15% and 22% in PCa and

SUBMITTER: Nghiem B 

PROVIDER: S-EPMC5730872 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature